Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Comment by Craiger02on Apr 12, 2021 4:48pm
116 Views
Post# 32981737

RE:RE:RE:Tilray is at $17 a share time to buy as much tilray-aprhia

RE:RE:RE:Tilray is at $17 a share time to buy as much tilray-aprhia
Bigginvestor wrote:
Craiger02 wrote: Just a helpful suggestion, but I'd be looking at buying Curaleaf before Tilray. 3 billion cap vs 12 billion. Great leadership and with the emmac acquisition, will dominate Europe. Tilray currently has no ability to sell in the US, while cura has over 100 locations and is grandfathered into NY legalization. 



no tilray merged with aprhia and tilray has huge market in Germany and Europe apriha has market in USA with a beer company so the combine company with beer will be huge compare to weed .they looking at $1 billion in revenue with the two mergers .



You are correct on portions of the above. I'm not comparing to canopy though. I'm speaking of Curaleaf vs tilray (currently trading around the same $ amount). 


although Tilray has an entry point into the US via beverage company, they currently do have any cultivation or retail setup. That's why I suggested Curaleaf which already operates over 100 locations. Expansion once safe act passes, will cost Tilray a huge multiple versus what is currently being paid. I think they're just too far behind right now to catch up starting from scratch. With NY, they will not be able to enter in all facets either with that way they structured legalization. As they currently have no licenses for medical, they will not be able to grow, distribute and retail themselves. Just some friendly advice. Hopefully whichever direction you choose works out well for you
 

<< Previous
Bullboard Posts
Next >>